What question did this study set out to answer?

This research investigates the effectiveness of implantable devices, specifically patient-activated antitachycardia pacemakers, in managing tachyarrhythmias.

May 1, 1984Pacing and Clinical Electrophysiology

Clinical Experience with Implantable Devices for Control of Tachyarrhythmias

View Full Paper

Ask AI

Bookmark

Why the study?

Does a patient-activated antitachycardia pacemaker reduce hospital admissions in patients with drug-resistant tachycardias?

Population

18 patients with drug-resistant tachycardias.

Comparison

Patient-activated antitachycardia pacemaker vs Historical control (3 months before implantation)

Design

Case_series

Follow-up

3-26 months

Authors

KDKarel den DulkElectrophysiology MBM BertholetUniversity of Liège PBPedro BrugadaElectrophysiology

Discussion

Member takes

Implication

May reduce admissions in refractory tachycardia; leaves open need for randomized confirmation before practice change.

Key Points

This research investigates the effectiveness of implantable devices, specifically patient-activated antitachycardia pacemakers, in managing tachyarrhythmias.
Eighteen patients with drug-resistant tachycardias implanted with antitachycardia pacemakers.
Follow-up duration ranged from 3 to 26 months to assess hypertrophic outcomes.
Data collected on the number of admissions for tachycardia termination before and after implantation.
Pre-implantation mean admissions were 2.1 per patient-month; post-implantation reduced to 0.02 admissions per patient-month.
6 patients had admissions due to device issues (2 defective activator, 2 inadequate control, 1 inappropriate use, 1 medication noncompliance).
Patients reported marked improvement in quality of life after device implantation.

Structured PICO

Does a patient-activated antitachycardia pacemaker reduce hospital admissions in patients with drug-resistant tachycardias?

Population

18 patients with drug-resistant tachycardias (6 with ventricular tachycardia, 3 with A-V nodal reentrant tachycardia, 4 with concealed accessory pathway, and 5 with WPW syndrome).

Intervention

Patient-activated antitachycardia pacemaker

Comparator

Historical control (3 months before implantation)

Outcome

Number of admissions for termination of tachycardiahard clinical

Patient-activated antitachycardia pacemakers are a safe and effective treatment that markedly reduces hospital admissions for patients with drug-resistant supraventricular and ventricular tachycardias.

Cite This Study

Dulk et al. (1984) studied this question.

synapsesocial.com/papers/6a7690cebe1ca4512ec3b067 https://doi.org/10.1111/j.1540-8159.1984.tb04949.x

View Full Paper

Ask AI

Bookmark

Clinical Experience with Implantable Devices for Control of Tachyarrhythmias

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Clinical Experience with Implantable Devices for Control of Tachyarrhythmias

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider